Veteran investor and operating executive focused on growth-stage and middle-market private equity investments, with experience across portfolio transformations, M&A and capital markets. Paul Zarling is known for leading operational turnarounds, serving on boards and driving deal execution, typically concentrating on industrials, business services and software-enabled services in North America. Market-oriented, value-creation approach with hands-on portfolio management.
Veteran investor and operating executive focused on growth-stage and middle-market private equity investments, with experience across portfolio transformations, M&A and capital markets. Paul Zarling is known for leading operational turnarounds, serving on boards and driving deal execution, typically concentrating on industrials, business services and software-enabled services in North America. Market-oriented, value-creation approach with hands-on portfolio management.
Veteran growth-stage and middle-market investor who prioritizes operational transformation and board-level stewardship to unlock enterprise value. Focuses on industrials, business services and software-enabled services across North America, deploying control and minority capital to accelerate M&A, digitization and margin expansion. Underwrites investments on disciplined cash-flow and operational KPI improvements, favors 3–7 year horizons, active portfolio management, clear exit pathways and conservative leverage to balance growth upside with downside protection.
Veteran growth-stage and middle-market investor who prioritizes operational transformation and board-level stewardship to unlock enterprise value. Focuses on industrials, business services and software-enabled services across North America, deploying control and minority capital to accelerate M&A, digitization and margin expansion. Underwrites investments on disciplined cash-flow and operational KPI improvements, favors 3–7 year horizons, active portfolio management, clear exit pathways and conservative leverage to balance growth upside with downside protection.
| Trades 254 | Longs Won 166/254 65% | Profit Factor 4.15 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2.27M |
| Average Win $470,033.2 | Best Trade (Aug 27) $36.95M | Sharpe Ratio -30.95 |
| Average Loss -$213,624.77 | Worst Trade (Sep 01) -$2.45M | Z-Score -3.41 (100%) |
| Commissions $0 | Avg. Trade Length 7m 1w 3d | Expectancy $233,175.32 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.08% | 1.14% | 12.08% |
| Consecutive Losing Trades | 1,046 | 941 | 837 | 732 | 628 | 523 | 418 | 314 | 209 | 105 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ADPV Adaptiv Select ETF | 2.47M | $69.92M | $110.29M | - | $40.37M | 57.73% | +0.09% |
AIS VistaShares Artificial Intelligence Supercycle ETF | 30,921 | $2.64M | $1.97M | - | -$667,584.88 | -25.31% | +0.473% |
AMDL GraniteShares 2x Long AMD ETF | 13,258 | $870,520.28 | $685,836.34 | - | -$184,683.94 | -21.22% | -3.345% |
ARKG ARK Genomic Revolution ETF | 61,321 | $2.58M | $2.36M | - | -$214,623.24 | -8.32% | -1.783% |
BEX Tradr 2X Long BE Daily ETF | 20,466 | $1.22M | $467,648.1 | - | -$756,422.9 | -61.8% | -0.738% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 6,533 | $599,270.94 | $598,945.44 | - | -$325.5 | -0.05% | +0.033% |
BOXX Alpha Architect 1-3 Month Boxx Fund | 154,198 | $17.93M | $18.15M | - | $217,419.23 | 1.21% | +0.06% |
CBON VanEck China Bond ETF | 48,632 | $1.16M | $1.16M | - | $5,349.08 | 0.46% | -0.008% |
CLOZ Panagram BBB-B CLO ETF | 112,467 | $2.97M | $2.97M | - | -$2,249.21 | -0.08% | -0.019% |
CVRT Calamos Convertible Equity Alternative ETF | 62,004 | $3.19M | $2.94M | - | -$250,093.4 | -7.84% | +0.211% |
FALN iShares Fallen Angels USD Bond ETF | 139,127 | $3.79M | $3.75M | - | -$44,520.15 | -1.17% | -0.111% |
FLRT Pacer Pacific Asset Floating Rate High Income ETF | 75,741 | $3.53M | $3.53M | - | -$0.17 | - | +0.064% |
JAAA Janus Henderson AAA CLO ETF | 18,053 | $911,496 | $911,676.5 | - | $180.5 | 0.02% | -0.336% |
JPIE JPMorgan Income ETF | 19,771 | $910,455 | $906,302.64 | - | -$4,152.36 | -0.46% | -0.087% |
| LABX LABX | 6,900 | $1.52M | $1.52M | - | - | - | 0.0 |
LLY Eli Lilly and Company | 2,286 | $1.34M | $2.63M | - | $1.28M | 95.51% | -0.531% |
MSFT Microsoft Corp. | 3,445 | $1.3M | $1.6M | - | $305,502.6 | 23.58% | +3.019% |
| NEBX NEBX | 49,971 | $2.94M | $2.94M | - | - | - | 0.0 |
PULS PGIM Ultra Short Bond ETF | 146,204 | $7.24M | $7.24M | - | $5,848.16 | 0.08% | -0.302% |
QLD ProShares Ultra QQQ | 23,771 | $2.3M | $1.99M | - | -$311,162.43 | -13.53% | +1.197% |